Clinical assessment of myocardial hibernation

Heart

Volumn 91, Issue 1, 2005, Pages 111-117

  Schinkel, Arend F L ^a   Bax, Jeroen J ^b   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; SPIRONOLACTONE; TECHNETIUM 99M; THALLIUM 201;

CELL VIABILITY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXCITATION CONTRACTION COUPLING; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; MYOCARDIAL HIBERNATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY;

ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL STUNNING; PROGNOSIS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 10844249406     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.042085     Document Type: Review

References (32)

1. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993;22:6A-13A.
2. Gheorghiade M, Bonow RO. Chronic heart failure in the United Stares - a manifestation of coronary artery disease. Circulation 1998;97:282-9. Review article on heart failure, focusing on the causes of heart failure, and related morbidity and mortality.
3. Diamond GA, Forrester JS, deLuz PL, et al. Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation. Am Heart J 1978;95:204-9. First observation that ischaemic non-infarcted myocardium can exist in a state of function hibernation.
4. Rohimtoolo SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985;72(suppl V):V123-35. Introduction of the concept of myocardial hibernation and recognition that left ventricular dysfunction may be reversible.
5. Box JJ, Poldermans D, Elhendy A, et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 1999;34:163-9.
6. Kloner RA, Bolli R, Marban E, et al. Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. Circulation 1998;97:1848-67. Article on the pathophysiology of myocardial stunning and hibernation.
7. Bargers M, Thoné F, Wouters L, et al. Structural correlates or regional myocardial dysfunction in patients with critical coronary artery stenosis: chronic hibernation? Cardiovasc Pathol 1993;2:237-45.
8. Vonoverschelde JL, Depre C, Gerber BL, et al. Time course of functional recovery after coronary artery bypass graft surgery in patients with chronic left ventricular ischemic dysfunction. Am J Cardiol 2000;85:1432-9.
9. Cwojg JM, Cwajg E, Nagueh SF, et al. End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: relation to rest-redistribution TI-201 tomography and dobutamine stress echocardiography. J Am Coll Cardiol 2000;35:1152-61. This article demonstrates that thinned myocardium is related to a low chance of recovery in contractile function after coronary revascularisation.
10. Cigarroa CG, deFilippi CR, Brickner E, et al. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993;88:430-6.
11. Rombaldi R, Poldermans D, Bax JJ, et al. Doppler tissue velocity sampling improves diagnostic accuracy during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. Eur Heart. J 2000;21:1091-8. This study shows that quantification of dobutamine stress echocardiography by Doppler tissue imaging improves identification of viable myocardium.
12. Shimoni S, Frangogiannis NG, Aggeli CJ, et al. Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography: comparison with dobutamine echocardiography and thallium-201 scintigraphy. Circulation 2003;107:538-44.
13. Dilzisian V, Rocco TP, Freedman NMT, et al. Enhanced detection of ischemic but viable myocardium by reinjection of thallium after stress redistribution imaging. N Engl J Med 1991;323:141-6.
14. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.
15. Gropler RJ, Geltman EM, Sampathkumaran K, et al. Comparison of carbon-11 acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol 1993;22:1587-97.
16. Yoshida K, Gould KL. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization. J Am Coll Cardiol 1993;22:984-97.
17. Bax JJ, Fath-Ordoubadi F, Boersma E, et al. Accuracy of PET in predicting functional recovery after revascularisation in patients with chronic ischaemic dysfunction: head-to-head comparison between blood flow, glucose utilisation and water-perfusable tissue fraction. Eur J Nucl Med Mol Imaging 2002;29:721-7.
18. Srinivasan G, Kitsiou AN, Bacharach SL, et al. [18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability? Circulation 1998;97:843-50.
19. Baer FM, Voth E, Schneider CA, et al. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation 1995;91:1006-15.
20. Baer FM, Theissen P, Schneider CA, et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998;31:1040-8. Study in 43 patients showing that quantitative assessment of dobutamine induced systolic wall thickening in chronic infarcts by MRI is a highly accurate predictor of functional recovery, and the presence of significantly reduced diastolic wall thickness reliably indicates irreversible myocardial damage.
21. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
22. Klein C, Nekolla SG, Bengel FM, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105:162-7.
23. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
24. Koch KC, vom Dahl J, Wenderdel M, et al. Myocardial viability assessment by endocardial electroanatomic mapping: comparison with metabolic imaging and functional recovery after coronary revascularization. J Am Coll Cardiol 2001;38:91-8.
25. Strauer BE, Kornowski R. Stem cell therapy in perspective. Circulation 2003;107:929-34. Review article discussing new and future developments in stem cell therapy and its potential use in clinical cardiology.
26. Pfeffer MA, Braunwald E, Moye LA, et al. on behalf of the SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial, N Engl J Med 1992;327:669-77.
27. Pitt B, Zannad F, Remme WJ, for the Randomized Aldactone Evaluation Study Investigators, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-17.
28. CIBIS-II Investigators. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13.
29. Schinkel AFL, Poldermans D, Vanoverschelde JL, et al. Incidence of recovery of contractile function following revascularization in patients with ischemic left ventricular dysfunction. Am J Cardiol 2004;93:14-7. This study involving 258 consecutive patients indicates that recovery of global function can be anticipated after myocardial revascularisation in almost 40% of patients with ischaemic cardiomyopathy.
30. Bax JJ, Poldermans D, Elhendy A, et al. Sensitivity, specificity, and predictive accuracies of various non-invasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 2001;26:141-86. A meta-analysis focusing an the comparison between non-invasive imaging modalities to assess hibernation.
31. Rizzello V, Schinkel AFL, Bax JJ, et al. Individual prediction of functional recovery after coronary revascularization in patients with ischemic cardiomyopathy: the scar-to-biphasic model. Am J Cardiol 2003;91:1406-9.
32. Schinkel AFL, Poldermans D, Rizzello V, et al. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization? J Thorac Caradiovasc Surg 2004;127:385-90.